Genetics and Clinicopathological Features in Retinal Diseases: Opportunities and Progress
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 5258
Special Issue Editor
Interests: genotype–phenotype correlation in retinal diseases; pediatric retinal vascular diseases; surgical retina
Special Issue Information
Dear Colleagues,
Understanding the underlying genetics behind various retinal diseases will pave the way for the future of precision medicine. As early as the 1970s, the first proof of principle ex vivo experiments has led to the proposal that gene therapy could be used to treat inherited monogenic disorders. The eye is a unique target as it is relatively immune-privileged. In 2017, the FDA first approved Voretigene Neparvovec for the treatment of bi-allelic RPE65 mutation associated retinal dystrophy. Since then, there has a been a proliferation of phase 1 to 3 trials treating various retinal diseases such as retinitis pigmentosa, achromatopsia, choroideremia, lebers hereditary optic neuropathy, X-linked juvenile retinoschisis, Stargardt’s disease and many others.
It is imperative that we increase our understanding of the genotype–phenotype correlation in various retinal diseases, in order to possibly develop treatment targets in the future.
This Special Issue aims to provide a platform and forum for scientists to showcase their research, ideas and novel findings. We aim to gather contributions from all aspects related to the genetics and clinical findings in retinal diseases that. We hope to increase the knowledge base in relation to this topic.
Dr. Andrew S.H. Tsai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genetics of retinal diseases
- genotype–phenotype correlation
- gene therapy
- genetic analysis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.